Novel TOR Inhibitor Rapalink-1 Extends Lifespan Through Gut Bacteria Enzyme Pathway
核心洞察
Researchers at Queen Mary University of London discovered that rapalink-1, a next-generation TOR (搜索) inhibitor under cancer (搜索) investigation, significantly extends chronological lifespan in yeast models.
The study revealed agmatinases (搜索), enzymes that break down agmatine from gut bacteria, act as essential metabolic regulators that keep TOR (搜索) activity in check and prevent premature aging.
Loss of agmatinase function caused cells to grow faster but age prematurely, demonstrating a critical trade-off between short-term growth and long-term survival.
Researchers from Queen Mary University of London have identified a promising new anti-aging drug class that extends lifespan by targeting a conserved cellular pathway active in both yeast and humans. The study, published in Communications Biology, demonstrates that rapalink-1, a next-generation TOR (搜索) inhibitor currently under investigation for cancer (搜索) therapy, significantly prolongs chronological lifespan in fission yeast models.
TOR Pathway Central to Aging Process
The Target of Rapamycin (TOR (搜索)) pathway serves as a central regulator of growth and aging, playing fundamental roles in age-related diseases including cancer (搜索) and neurodegeneration (搜索). This conserved signaling pathway, active across species from yeast to humans, has already emerged as a major focus of anti-aging and cancer research, with established drugs like rapamycin showing promise in extending healthy lifespan in animal studies.
The research team, led by Juhi Kumar, Kristal Ng, and Charalampos Rallis, found that rapalink-1 not only slowed aspects of yeast cell growth but also significantly extended lifespan by working through TORC1 (搜索)—the growth-promoting arm of the TOR (搜索) pathway.
Gut Bacteria Enzymes Reveal New Longevity Mechanism
The study unexpectedly revealed a crucial role for agmatinases (搜索), a set of enzymes that break down the metabolite agmatine into polyamines. These enzymes function as part of a previously unknown "metabolic feedback loop" that maintains TOR (搜索) activity in check, representing a new layer of metabolic control over the aging process.
"By showing that agmatinases (搜索) are essential for healthy aging, we've uncovered a new layer of metabolic control over TOR (搜索)—one that may be conserved in humans," said Dr. Rallis. "Because agmatine is produced by diet and gut microbes, this work may help explain how nutrition and the microbiome influence aging."
Growth-Longevity Trade-off Identified
The research revealed a critical trade-off between short-term growth and long-term survival. When agmatinase function was lost, cells grew faster but aged prematurely, highlighting the delicate balance required for healthy aging. Conversely, supplementing yeast with agmatine or putrescine, compounds linked to this pathway, promoted longevity and benefited cells under certain conditions.
Clinical Implications and Cautions
While the findings point to new strategies for longevity that combine TOR (搜索)-targeting drugs with dietary or microbial interventions, researchers emphasize caution regarding current supplementation approaches. Although agmatine supplements are commercially available, Dr. Rallis stresses important limitations.
"We should be cautious about consuming agmatine for growth or longevity purposes," Rallis noted. "Our data indicate the agmatine supplementation can be beneficial for growth only when certain metabolic pathways related to arginine breakdown are intact. In addition, agmatine does not always promote beneficial effects as it can contribute to certain pathologies."
The study suggests that agmatine supplementation can be beneficial only when specific metabolic pathways in the body related to arginine breakdown remain intact, indicating the need for personalized approaches to longevity interventions.
Future Research Directions
The research team believes understanding how TORC1 (搜索) activity is regulated may prove beneficial in both normal aging and pathological states, as well as in cancer (搜索) treatment where TOR (搜索) plays important roles. The discovery of this metabolic feedback loop involving gut bacteria-derived compounds opens new avenues for developing targeted anti-aging therapies that work in concert with dietary and microbiome interventions.